beta-Nicotinamide mononucleotide, reduced form (disodium) (Standard), CAS [[108347-85-9]]

Produktübersicht

• Artikelname: beta-Nicotinamide mononucleotide, reduced form (disodium) (Standard), CAS [[108347-85-9]]
• Artikelnummer: MCE-HY-W615108BR
• Hersteller Artikelnummer: HY-W615108BR
• Alternativnummer: MCE-HY-W615108BR-100MG, MCE-HY-W615108BR-50MG, MCE-HY-W615108BR-25MG, MCE-HY-W615108BR-10MG, MCE-HY-W615108BR-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: NMNH (disodium) (Standard)

Produktbeschreibung

beta-Nicotinamide mononucleotide, reduced form (disodium) (Standard) is the analytical standard of beta-Nicotinamide mononucleotide, reduced form (disodium) (HY-W615108B). This product is intended for research and analytical applications. beta-Nicotinamide mononucleotide, reduced form (NMNH) disodium is an orally active reduced version of beta-Nicotinamide mononucleotide (HY-F0004). beta-Nicotinamide mononucleotide, reduced form disodium can significantly increase the levels of NAD+ and NADH, inhibit glycolysis, the tricarboxylic acid cycle, and cell growth, with its effects being dependent on nicotinamide mononucleotide adenylyltransferase (NMNAT)[1][2].

Produkteigenschaften

• Molekulargewicht: 380.20
• CAS Nummer: [108347-85-9]
• Formel: C11H15N2Na2O8P
• Target-Kategorie: Endogenous Metabolite,Reference Standards

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference Standards